#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Scleroderma associated digital ulcer Glomerulonephritis rapidly progressive Myelodysplastic syndrome with excess blasts Vascular calcification Clear cell papillary renal cell carcinoma Angiosarcoma recurrent Non-Hodgkin's lymphoma refractory Soft tissue necrosis Idiopathic pulmonary fibrosis Neoplasm malignant Arrhythmia Cerebral amyloid angiopathy Hypochondroplasia Chronic hepatitis B More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Diagnostics Pelizaeus-Merzbacher disease – Life with Disease Gastrointestinal stromal tumour – Basic Information Idiopathic inflammatory myopathy – Basic Information Sarcoidosis – Diagnostics Primary hyperoxaluria – Trials in Disease Alveolar rhabdomyosarcoma – Life with Disease Haemophilia A with anti factor VIII – Trials in Disease Antithrombin III deficiency – Trials in Disease Congenital hypotransferrinaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Obinutuzumab Prasinezumab Atropine Sulfate Monohydrate Human Coagulation Factor Ii Cipaglucosidase Alfa Bi 764532 Enlicitide Chloride Digitoxin Oxybuprocaine Lysine Aspirin Immunostimulants Gallium (68Ga) Evx-01 Odronextamab ADX-324 Ferric Carboxymaltose Ranitidine Trospium Chloride Dabigatran Etexilate Liquid Paraffin More therapies…

    Learn about Your Condition

    Diabetic autonomic neuropathy Intracranial calcification Idiopathic pulmonary fibrosis Upper limb fracture Krabbe's disease Extraskeletal ossification Myeloid leukaemia Breast cancer stage IV Muscle strain Endometrial cancer recurrent Malignant melanoma Spinal cord injury Breast cancer metastatic Immunodeficiency Strongyloidiasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fondation A De Rothschild

Fondation A De Rothschild

29 Rue Manin, Paris, 75019, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Belgium France Germany Italy Spain

  • Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Diroximel Fumarate
    • Interferon Beta-1A
    • Peginterferon Beta-1A
    France

  • Study on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    • Uveitis
    Investigated Drugs:
    • Adalimumab
    • Tocilizumab
    France

  • Study on Retinoblastoma Treatment Using Etoposide, Carboplatin, and Melphalan for Patients with Specific Eye Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Carboplatin
    • Etoposide
    • Melphalan
    France

  • Study on Intra-Arterial Thrombolysis with Alteplase for Patients with Acute Ischemic Stroke in the Anterior Circulation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Alteplase
    France

  • Study on Colchicine and Ticagrelor for Preventing Ischemic Stroke in Patients with Atherosclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Colchicine
    France

  • Study on the Effects of Dornase Alfa for Patients with Subarachnoid Hemorrhage to Improve Independence After 6 Months

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aneurysm ruptured
    Investigated Drugs:
    • Dornase Alfa
    France

  • Study on Tenecteplase and Alteplase for Patients with Acute Ischemic Stroke Due to Basilar Artery Blockage

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alteplase
    • Tenecteplase
    France

  • Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis

    Recruiting

    3 1
    Investigated Diseases:
    • Eyelid ptosis
    Investigated Drugs:
    • Oxymetazoline Hydrochloride
    Bulgaria Czechia France Germany Hungary Italy +4

  • Study on Bevacizumab for Patients with Symptomatic Cerebral Arteriovenous Malformations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral arteriovenous malformation haemorrhagic
    Investigated Drugs:
    • Bevacizumab
    France
Previous Page
1 2 3 4 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!